Abionyx Pharma (France) Market Value

ABNX Stock  EUR 1.24  0.02  1.64%   
Abionyx Pharma's market value is the price at which a share of Abionyx Pharma trades on a public exchange. It measures the collective expectations of Abionyx Pharma SA investors about its performance. Abionyx Pharma is trading at 1.24 as of the 23rd of December 2024, a 1.64% up since the beginning of the trading day. The stock's open price was 1.22.
With this module, you can estimate the performance of a buy and hold strategy of Abionyx Pharma SA and determine expected loss or profit from investing in Abionyx Pharma over a given investment horizon. Check out Abionyx Pharma Correlation, Abionyx Pharma Volatility and Abionyx Pharma Alpha and Beta module to complement your research on Abionyx Pharma.
Symbol

Please note, there is a significant difference between Abionyx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abionyx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abionyx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Abionyx Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Abionyx Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Abionyx Pharma.
0.00
11/23/2024
No Change 0.00  0.0 
In 31 days
12/23/2024
0.00
If you would invest  0.00  in Abionyx Pharma on November 23, 2024 and sell it all today you would earn a total of 0.00 from holding Abionyx Pharma SA or generate 0.0% return on investment in Abionyx Pharma over 30 days. Abionyx Pharma is related to or competes with Hydrogen Refueling, OSE Pharma, Biophytis, and Abivax SA. ABIONYX Pharma SA, a biopharmaceutical company, discovers and develops high density lipoprotein therapies for the treatm... More

Abionyx Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Abionyx Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Abionyx Pharma SA upside and downside potential and time the market with a certain degree of confidence.

Abionyx Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Abionyx Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Abionyx Pharma's standard deviation. In reality, there are many statistical measures that can use Abionyx Pharma historical prices to predict the future Abionyx Pharma's volatility.
Hype
Prediction
LowEstimatedHigh
0.061.243.82
Details
Intrinsic
Valuation
LowRealHigh
0.051.063.64
Details

Abionyx Pharma SA Backtested Returns

Abionyx Pharma SA secures Sharpe Ratio (or Efficiency) of -0.0157, which signifies that the company had a -0.0157% return per unit of risk over the last 3 months. Abionyx Pharma SA exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Abionyx Pharma's Mean Deviation of 1.81, standard deviation of 2.58, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.58, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Abionyx Pharma are expected to decrease at a much lower rate. During the bear market, Abionyx Pharma is likely to outperform the market. At this point, Abionyx Pharma SA has a negative expected return of -0.0405%. Please make sure to confirm Abionyx Pharma's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Abionyx Pharma SA performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.14  

Insignificant predictability

Abionyx Pharma SA has insignificant predictability. Overlapping area represents the amount of predictability between Abionyx Pharma time series from 23rd of November 2024 to 8th of December 2024 and 8th of December 2024 to 23rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Abionyx Pharma SA price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Abionyx Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient0.14
Spearman Rank Test-0.19
Residual Average0.0
Price Variance0.0

Abionyx Pharma SA lagged returns against current returns

Autocorrelation, which is Abionyx Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Abionyx Pharma's stock expected returns. We can calculate the autocorrelation of Abionyx Pharma returns to help us make a trade decision. For example, suppose you find that Abionyx Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Abionyx Pharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Abionyx Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Abionyx Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Abionyx Pharma stock over time.
   Current vs Lagged Prices   
       Timeline  

Abionyx Pharma Lagged Returns

When evaluating Abionyx Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Abionyx Pharma stock have on its future price. Abionyx Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Abionyx Pharma autocorrelation shows the relationship between Abionyx Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Abionyx Pharma SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Abionyx Stock

Abionyx Pharma financial ratios help investors to determine whether Abionyx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abionyx with respect to the benefits of owning Abionyx Pharma security.